Arkolith/Insider Trading/SONN/Form 4

Dyrness Albert D.

DirectorSonnet BioTherapeutics Holdings, Inc. (SONN) · full profile →Form 4 · filed Jul 15, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 11, 2023Grant(A)4K——5K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001641172-25-019785) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML